News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Lombard Medical Technologies Gets Conditional FDA Approval for US Trial of Aorfix


5/29/2007 4:46:31 PM

LONDON (Thomson Financial) - Lombard Medical Technologies PLC said it has received conditional approval from the US Food and Drug Administration for clinical trialling of its Aorfix endovascular stent graft used in the treatment of abdominal aortic aneurysms.

Read at press release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES